Buscador de publicaciones

Publicaciones

  • Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng HK, Li X, Mu K, Trabelsi S, Brahim DH, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Suñol M, de Torres C, Cruz-Martínez O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily MA, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, von Bueren AO, Baudis M, Resnick A and Jones C.

    Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

    Cancer Cell . 32(4): 520-537. Nº de citas: 773

    [doi:10.1016/j.ccell.2017.08.017]

  • Boeva V, Louis-Brennetot C, Peltier A, Durand S, Pierre-Eugène C, Raynal V, Etchevers HC, Thomas S, Lermine A, Daudigeos-Dubus E, Geoerger B, Orth MF, Grünewald TGP, Diaz E, Ducos B, Surdez D, Carcaboso AM, Medvedeva I, Deller T, Combaret V, Lapouble E, Pierron G, Grossetête-Lalami S, Baulande S, Schleiermacher G, Barillot E, Rohrer H, Delattre O and Janoueix-Lerosey I.

    Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries

    NATURE GENETICS . 49(9): 1408-1413. Nº de citas: 315

    [doi:10.1038/ng.3921]

  • Cockle JV, Brüning-Richardson A, Scott KJ, Thompson J, Kottke T, Morrison E, Ismail A, Carcaboso AM, Rose A, Selby P, Conner J, Picton S, Short S, Vile R, Melcher A and Ilett E.

    Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion

    MOLECULAR THERAPY-ONCOLYTICS . 5: 75-86. Nº de citas: 22

    [doi:10.1016/j.omto.2017.04.002]

  • Haque F, Varlet P, Puntonet J, Storer L, Bountali A, Rahman R, Grill J, Carcaboso AM, Jones C, Layfield R and Grundy RG.

    Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours

    Acta neuropathologica communications . 5: 45-45. Nº de citas: 28

    [doi:10.1186/s40478-017-0449-1]

  • Sewing AC, Lagerweij T, van Vuurden DG, Meel MH, Veringa SJ, Carcaboso AM, Gaillard PJ, Peter Vandertop W, Wesseling P, Noske D, Kaspers GJ and Hulleman E.

    Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma

    JOURNAL OF NEUROSURGERY-PEDIATRICS . 19(5): 518-530. Nº de citas: 23

    [doi:10.3171/2016.9.PEDS16152]

  • Mohammad F, Weissmann S, Leblanc B, Pandey DP, Højfeldt JW, Comet I, Zheng C, Johansen JV, Rapin N, Porse BT, Tvardovskiy A, Jensen ON, Gene-Olaciregui N, Lavarino C, Suñol M, de Torres C, Mora J, Carcaboso AM and Helin K.

    EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

    NATURE MEDICINE . 23(4): 483-492. Nº de citas: 424

    [doi:10.1038/nm.4293]

  • Monterrubio C, Paco-Mercader S, Gene-Olaciregui N, Pascual-Pastó G, Vilà-Ubach M, Cuadrado-Vilanova M, Ferrandiz MM, Castillo-Ecija H, Glisoni R, Kuplennik N, Jungbluth A, de Torres C, Lavarino C, Cheung NV, Mora J, Sosnik A and Carcaboso AM.

    Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8

    JOURNAL OF CONTROLLED RELEASE . 255: 108-119. Nº de citas: 36

    [doi:10.1016/j.jconrel.2017.04.016]

  • Hennika T, Hu G, Gene-Olaciregui N, Barton KL, Ehteda A, Chitranjan A, Chang C, Gifford AJ, Tsoli M, Ziegler DS, Carcaboso AM and Becher OJ.

    Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models

    PLoS One . 12(1): . Nº de citas: 130

    [doi:10.1371/journal.pone.0169485]

  • Fang X, Zhou W, Wu Q, Huang Z, Shi Y, Yang K, Chen C, Xie Q, Mack SC, Wang X, Carcaboso AM, Sloan AE, Ouyang G, McLendon RE, Bian XW, Rich JN and Bao S.

    Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination

    JOURNAL OF EXPERIMENTAL MEDICINE . 214(1): 245-267. Nº de citas: 124

    [doi:10.1084/jem.20151673]

  • Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.

    Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

    CANCER LETTERS . 380(1): 10-19. Nº de citas: 27

    [doi:10.1016/j.canlet.2016.06.012]